Medium materiality6/10
Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist lowers JAZZ target to $254; current price $245.54; priceChangeSinceSignal 1.12.
- Truist lowers target to $254
- Current price $245.54
Key facts
- 01
Target: $254
- 02
Posted price: $245.54
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.